Brand Recall Hub

Jamp Recalls in Canada

68 recalls found for Jamp. Data sourced from Health Canada, CFIA, and Transport Canada. Updated daily.

68 Jamp Recalls

Health Products Type II
2026-01-05

JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)

Product quality

View recall details →

Health Products Type III
2025-11-19

JAMP-Risperidone 0.25mg: Out of specification (Stability)

Product quality

View recall details →

Health Products Type III
2025-10-27

JAMP SERTRALINE 50mg: One lot recalled as some bottles may contain 25 mg capsules

Product safety

View recall details →

Health Products Type II
2025-09-23

Jamp-Senna 8.6 mg tablet; Out of Specification (Total yeast & mold count; total aerobic microbiological count)

Product quality

View recall details →

Health Products Type II
2025-08-13

Jamp Bisoprolol 5 mg tablet: may contain a foreign tablet

Product quality

View recall details →

Health Products Type II
2025-06-10

Jamp-Hydralazine tablet: Affected lot may contain Jamp-Hydralazine 10 mg tablets

Product safety

View recall details →

Health Products Type III
2025-05-30

JAMP-RISPERIDONE: may contain foreign matter particles

Product safety

View recall details →

Health Products Type II
2025-05-28

JAMP-ASA 81MG EC: may contain foreign tablets containing acetaminophen and methocarbamol

Product safety

View recall details →

Health Products Type I
2025-05-05

JAMP-Pregabalin: One lot recalled as some bottles may contain 150 mg capsules

Product safety

View recall details →

Health Products Type III
2025-05-05

JAMP Pentoxifylline SR 400mg: Affected lot may contain Sitagliptin 100mg tablets.

Product safety

View recall details →

Other
2025-05-03

JAMP-Pregabalin 50 mg: One lot recalled as some bottles may contain 150 mg capsules

Product safety

View recall details →

Health Products Type II
2025-04-24

JAMP-MONTELUKAST 10mg: may contain foreign fragments of pink candesartan tablets

Contamination

View recall details →

Health Products
2025-04-22

JAMP Valproic Acid Oral Solution: Presence of large solid crystals in affected lots

Product quality

View recall details →

Other
2025-04-18

Three lots of JAMP Valproic Acid Oral Solution recalled

Product quality

View recall details →

Health Products Type III
2025-03-11

Jamp Calcium Carbonate 500 + Vitamin D 1000 Tablet; Out of Specification (Dissolution)

Product quality

View recall details →

Health Products Type II
2025-03-06

Jamp K8 Tablet; Out of Specification (Dissolution)

Product quality

View recall details →

Health Products Type III
2025-03-03

Jamp Itraconazole Oral Solution: Presence of crystalline particles

Product quality

View recall details →

Health Products Type II
2025-02-05

SENNA Tablet USP ; JAMP Senna ; Jamp - SENNA: total counts of yeasts and molds are out of specification

Product safety

View recall details →

Health Products Type II
2025-01-07

JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule

Product quality

View recall details →

Health Products Type II
2024-12-23

Jamp Amoxi Clav Suspension; Out of specification

Product quality

View recall details →

Health Products Type II
2024-11-14

JAMP-FeR: Yeasts and molds count is out of specification

Product quality

View recall details →

Health Products Type II
2024-10-15

Jamp-Finasteride tablet; Out-of-specification (Finasteride content)

Product quality

View recall details →

Health Products Type II
2024-09-11

Jamp Telmisartan-HCT tablet; Out-of-Specification (Assay)

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Acetaminophen tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-09

Jamp-Telmisartan tablet: Overweight & Underweight tablets

Product quality

View recall details →

Health Products Type I
2024-09-06

JAMP-Clopidogrel : may contain overweight or underweight tablets

Product quality

View recall details →

Health Products Type II
2024-09-06

JAMP-Pyridostigmine Bromide; Overweight & Underweight tablets

Product quality

View recall details →

Other
2024-09-05

All lots of JAMP-Clopidogrel 75 mg and AG-Clopidogrel 75 mg tablets recalled due to possible incorrect dose, which may pose health risks

Product safety - Dosage

View recall details →

Health Products Type II
2024-08-30

JAMP Pantoprazole Sodium 40mg: Affected lots may contain oversized or undersized tablets

Product safety

View recall details →

Health Products Type II
2024-08-20

JAMP Pyridostigmine Bromide 60mg: Affected lot contains overweight or underweight tablets.

Product safety

View recall details →

Showing 30 of 68 recalls. View all →